BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37151886)

  • 1. Drug Repurposing Flubendazole to Suppress Tumorigenicity via PCSK9-dependent Inhibition and Potentiate Lenvatinib Therapy for Hepatocellular Carcinoma.
    Jin W; Yu J; Su Y; Lin H; Liu T; Chen J; Ge C; Zhao F; Geng Q; Mao L; Jiang S; Cui Y; Chen T; Jiang G; Li J; Miao C; Xiao X; Li H
    Int J Biol Sci; 2023; 19(7):2270-2288. PubMed ID: 37151886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Hedgehog signalling in CD133-positive hepatocellular carcinoma: improving Lenvatinib therapeutic efficiency.
    Hu Q; Hu X; Zhang L; Zhao Y; Li L
    Med Oncol; 2021 Mar; 38(4):41. PubMed ID: 33730237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human sulfatase 2 inhibitor 2,4-disulfonylphenyl-tert-butylnitrone (OKN-007) has an antitumor effect in hepatocellular carcinoma mediated via suppression of TGFB1/SMAD2 and Hedgehog/GLI1 signaling.
    Zheng X; Gai X; Han S; Moser CD; Hu C; Shire AM; Floyd RA; Roberts LR
    Genes Chromosomes Cancer; 2013 Mar; 52(3):225-36. PubMed ID: 23109092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Fasudil as a collaborator to promote the anti-tumor effect of lenvatinib in hepatocellular carcinoma by inhibiting GLI2-mediated hedgehog signaling pathway.
    Huang Y; Wang S; Zhang X; Yang C; Wang S; Cheng H; Ke A; Gao C; Guo K
    Pharmacol Res; 2024 Feb; 200():107082. PubMed ID: 38280440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal SMO to trigger Hedgehog pathway.
    Xia Y; Zhen L; Li H; Wang S; Chen S; Wang C; Yang X
    Cell Death Dis; 2021 Mar; 12(4):326. PubMed ID: 33771969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia Accelerates Aggressiveness of Hepatocellular Carcinoma Cells Involving Oxidative Stress, Epithelial-Mesenchymal Transition and Non-Canonical Hedgehog Signaling.
    Liu Z; Tu K; Wang Y; Yao B; Li Q; Wang L; Dou C; Liu Q; Zheng X
    Cell Physiol Biochem; 2017; 44(5):1856-1868. PubMed ID: 29237157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flubendazole elicits anti-cancer effects via targeting EVA1A-modulated autophagy and apoptosis in Triple-negative Breast Cancer.
    Zhen Y; Zhao R; Wang M; Jiang X; Gao F; Fu L; Zhang L; Zhou XL
    Theranostics; 2020; 10(18):8080-8097. PubMed ID: 32724459
    [No Abstract]   [Full Text] [Related]  

  • 8. PCSK9 Suppresses M2-Like Tumor-Associated Macrophage Polarization by Regulating the Secretion of OX40L from Hepatocellular Carcinoma Cells.
    Hu J; Zhang M; Gui L; Wan Q; Zhong J; Bai L; He M
    Immunol Invest; 2022 Aug; 51(6):1678-1693. PubMed ID: 35078374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA circIPO11 drives self-renewal of liver cancer initiating cells via Hedgehog signaling.
    Gu Y; Wang Y; He L; Zhang J; Zhu X; Liu N; Wang J; Lu T; He L; Tian Y; Fan Z
    Mol Cancer; 2021 Oct; 20(1):132. PubMed ID: 34649567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL2/CCR2 axis induces hepatocellular carcinoma invasion and epithelial-mesenchymal transition in vitro through activation of the Hedgehog pathway.
    Zhuang H; Cao G; Kou C; Liu T
    Oncol Rep; 2018 Jan; 39(1):21-30. PubMed ID: 29115520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
    Chen B; Wei W; Ma L; Yang B; Gill RM; Chua MS; Butte AJ; So S
    Gastroenterology; 2017 Jun; 152(8):2022-2036. PubMed ID: 28284560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dbx2 exhibits a tumor-promoting function in hepatocellular carcinoma cell lines
    Hu YT; Li BF; Zhang PJ; Wu D; Li YY; Li ZW; Shen L; Dong B; Gao J; Zhu X
    World J Gastroenterol; 2019 Feb; 25(8):923-940. PubMed ID: 30833799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular retinol binding protein-1 inhibits cancer stemness via upregulating WIF1 to suppress Wnt/β-catenin pathway in hepatocellular carcinoma.
    Liu X; Shan W; Li T; Gao X; Kong F; You H; Kong D; Qiao S; Tang R
    BMC Cancer; 2021 Nov; 21(1):1224. PubMed ID: 34775955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric nanoparticle-encapsulated hedgehog pathway inhibitor HPI-1 (NanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinoma.
    Xu Y; Chenna V; Hu C; Sun HX; Khan M; Bai H; Yang XR; Zhu QF; Sun YF; Maitra A; Fan J; Anders RA
    Clin Cancer Res; 2012 Mar; 18(5):1291-302. PubMed ID: 21868763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sophoridine suppresses lenvatinib-resistant hepatocellular carcinoma growth by inhibiting RAS/MEK/ERK axis via decreasing VEGFR2 expression.
    Zhao Z; Zhang D; Wu F; Tu J; Song J; Xu M; Ji J
    J Cell Mol Med; 2021 Jan; 25(1):549-560. PubMed ID: 33210432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways.
    Wang J; Yu H; Dong W; Zhang C; Hu M; Ma W; Jiang X; Li H; Yang P; Xiang D
    Gastroenterology; 2023 May; 164(6):990-1005. PubMed ID: 36764493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actinidia chinensis Planch root extract inhibits cholesterol metabolism in hepatocellular carcinoma through upregulation of PCSK9.
    He M; Hou J; Wang L; Zheng M; Fang T; Wang X; Xia J
    Oncotarget; 2017 Jun; 8(26):42136-42148. PubMed ID: 28178673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells.
    Kim Y; Yoon JW; Xiao X; Dean NM; Monia BP; Marcusson EG
    Cancer Res; 2007 Apr; 67(8):3583-93. PubMed ID: 17440069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin exerts anti-tumor effects via Sonic hedgehog signaling pathway by targeting AMPK in HepG2 cells.
    Hu A; Hu Z; Ye J; Liu Y; Lai Z; Zhang M; Ji W; Huang L; Zou H; Chen B; Zhong J
    Biochem Cell Biol; 2022 Apr; 100(2):142-151. PubMed ID: 34990285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-Wide CRISPR/Cas9 Library Screening Identified that DUSP4 Deficiency Induces Lenvatinib Resistance in Hepatocellular Carcinoma.
    Huang S; Ma Z; Zhou Q; Wang A; Gong Y; Li Z; Wang S; Yan Q; Wang D; Hou B; Zhang C
    Int J Biol Sci; 2022; 18(11):4357-4371. PubMed ID: 35864956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.